Back to School: How biopharma can reboot drug development. Access exclusive analysis here
MEDI will expand production of its FluMist influenza vaccine by one million doses to help alleviate flu vaccine shortages,
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury